5 amino 1mq nnmt inhibitor studies 5-Amino-1MQ 50mg | Research Compound 5-Amino-1MQ 5mg & 50mg |

Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604

Understanding its Chemical Structure At its core, 5-Amino-1MQ is a small molecule that acts like a peptide

Metabolic approaches: GLP-1 Incretins (semaglutide): appetite suppression | GLP-1/GIP incretins (tirzepatide): dual hormonal agonism | 5-Amino-1MQ: NNMT enzyme inhibition a non-hormonal mechanism, directly targeting lipid and NAD+ metabolism

While Semaglutide has well-documented effects, it has its own risks

| 06.16.26 | 8 min read

5-Amino-1MQ is a small, non-hormonal molecule that targets lipid metabolism via NNMT inhibition and NAD+ preservation, without affecting appetite